Mono Pharmacare (NSE:MONOPHARMA) Construction In Progress: ₹0 Mil (As of Sep. 2025)


NSE:MONOPHARMA Mono Pharmacare Ltd NSE:MONOPHARMA
9 GF Score
Price ₹11.00
! 6 Warning Signs
View Full Analysis

What is Mono Pharmacare Construction In Progress?

Mono Pharmacare NSE:MONOPHARMA -1.79% 9 Construction In Progress is ₹0 Mil as of Sep. 2025. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 9/100. The stock has 6 warning signs investors should review.

Mono Pharmacare's quarterly construction in progress stayed the same from Sep. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) and stayed the same from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹0 Mil).

Mono Pharmacare's annual construction in progress stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil) but then increased from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil).

Mono Pharmacare Construction In Progress Historical Data

* Premium members only.

The historical data trend for Mono Pharmacare's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mono Pharmacare Construction In Progress Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Construction In Progress
0.00 0.00 0.00 0.00 0.18

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Construction In Progress Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.18 0.18 0.18
NSE:MONOPHARMA
9GF Score
Mono Pharmacare Ltd NSE:MONOPHARMA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mono Pharmacare Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0 Mil mean?
Mono Pharmacare (NSE:MONOPHARMA) has a Construction In Progress of ₹0 Mil as of Sep. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Mono Pharmacare and its competitors.
Is Mono Pharmacare's Construction In Progress too high?
Mono Pharmacare's current Construction In Progress is ₹0 Mil. Overall, Mono Pharmacare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's Construction In Progress compare to competitors?
Mono Pharmacare's Construction In Progress of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Mono Pharmacare and its competitors. Mono Pharmacare's current Construction In Progress is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current Construction In Progress of ₹0 Mil. The current Construction In Progress is ₹0 Mil. Mono Pharmacare's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current Construction In Progress is ₹0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mono Pharmacare Business Description

Address 1A, Krinkal Apartment, Opposite Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
9GF Score

Get the complete analysis for NSE:MONOPHARMA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.00
Price